Reportlinker.com has announced the addition of a new market research report titled ‘Global Nanobiotechnology Industry’ to its offering.
The new report discusses the global markets for nanobiotechnology in detail. Technology segments covered in the report include nanomaterials and nanodevices/tools. Nanomaterials analyzed in the report include fullerenes, nanotubes, nanostrucutred materials and membranes, nanocomposites, solid inorganic nanoparticles and other nanomaterials.
Geographic markets discussed in the report include the United States, Europe, Japan and Rest of World. The report includes annual forecast data for the aforementioned geographical markets for the period between 2009 and 2017. It also includes historic analysis for a period of six years for these regions. Market and analytics data are obtained from primary and secondary search.
Key topics covered in the report include Introduction, Methodology and Product Definitions; Executive Summary; Industry Overview; Market Dynamics; Industry Challenges and Issues; Industry Structure; Nanobio’s Epochal Strides In Modern Medicine; Conceptual Overview; Global Research Centers and Institutions; Strategic Corporate Developments; Strategic Corporate Developments - a Historic Perspective Builder; Focus on Select Global Players; Global Market Perspective; Market; and Competitive Landscape.
The comprehensive report includes profiles of 117 major and niche players operating in the global nanobiotechnology market. The companies profiled in the report include Zyvex Instruments, Unidym, SkyePharma Pharmaceuticals, Dendritic Nanotechnologies, Starpharma Holdings, Sigma Aldrich, pSivida, Nanophase Technologies, Nanogen, NanoBio, Life Technologies, Gilead Sciences, Flamel Technologies, Aduro BioTech, Elitech Group, Elan Pharmaceuticals, Celgene, Biosante Phosphate Pharmaceuticals, Asklepios BioPharmaceutical, Agilent Technologies, Calando Pharmaceuticals, and Arrowhead Research.